Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
14 participants
INTERVENTIONAL
2008-11-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat
NCT03284034
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
NCT07102459
DualSculpting the Abdomen Using CoolSculpting
NCT02941146
Non-Invasive Reduction of Abdominal Fat Utilizing the CoolFlex and eZ App 6.3 Applicators
NCT01377740
CoolSculpting in the Abdomen Using Applicator With and Without CCI
NCT02787850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ATX-101
ATX-101
ATX-101 single doses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ATX-101
ATX-101 single doses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kythera Biopharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kythera Biopharmaceuticals, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Walker, M.D., Ph.D.
Role: STUDY_DIRECTOR
Kythera Biopharmaceuticals, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Francisco, California, United States
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATX-101-08-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.